Bevacizumab in Combination with TAS‐102 Improves Clinical...
Treatment with Bmab in combination with TAS-102 is significantly associated with improved clinical outcomes in patients with mCRC.doi:10.1634/theoncologist.2019-0541John Wiley & Sons, LtdThe Oncologist